Montserrat Laguno
Infectious Diseases Service
Hospital Clínic
Barcelona
Spain
Name/email consistency: high
- Randomized trial comparing pegylated interferon alpha-2b versus pegylated interferon alpha-2a, both plus ribavirin, to treat chronic hepatitis C in human immunodeficiency virus patients. Laguno, M., Cifuentes, C., Murillas, J., Veloso, S., Larrousse, M., Payeras, A., Bonet, L., Vidal, F., Milinkovic, A., Bassa, A., Villalonga, C., Pérez, I., Tural, C., Martínez-Rebollar, M., Calvo, M., Blanco, J.L., Martínez, E., Sánchez-Tapias, J.M., Gatell, J.M., Mallolas, J. Hepatology (2009)
- Prevalence and clinical relevance of occult hepatitis B in the fibrosis progression and antiviral response to INF therapy in HIV-HCV-coinfected patients. Laguno, M., Larrousse, M., Blanco, J.L., Leon, A., Milinkovic, A., Martínez-Rebozler, M., Loncá, M., Martinez, E., Sanchez-Tapias, J.M., de Lazzari, E., Gatell, J.M., Costa, J., Mallolas, J. AIDS Res. Hum. Retroviruses (2008)
- Predictive value of early virologic response in HIV/hepatitis C virus-coinfected patients treated with an interferon-based regimen plus ribavirin. Laguno, M., Larrousse, M., Murillas, J., Blanco, J.L., León, A., Milinkovic, A., Loncá, M., Martinez, E., Sánchez-Tapias, J.M., de Lazzari, E., Gatell, J.M., Costa, J., Mallolas, J. J. Acquir. Immune Defic. Syndr. (2007)
- Incidence and risk factors for mitochondrial toxicity in treated HIV/HCV-coinfected patients. Laguno, M., Milinkovic, A., de Lazzari, E., Murillas, J., Martínez, E., Blanco, J.L., Loncá, M., Biglia, A., Leon, A., García, M., Larrousse, M., García, F., Miró, J.M., Gatell, J.M., Mallolas, J. Antivir. Ther. (Lond.) (2005)
